Your browser is no longer supported. Please, upgrade your browser.
CERC Cerecor Inc. daily Stock Chart
Cerecor Inc.
Index- P/E- EPS (ttm)-0.67 Insider Own0.90% Shs Outstand53.94M Perf Week42.92%
Market Cap174.29M Forward P/E- EPS next Y-0.49 Insider Trans- Shs Float51.37M Perf Month29.72%
Income-33.30M PEG- EPS next Q-0.11 Inst Own60.00% Short Float1.00% Perf Quarter5.90%
Sales6.90M P/S25.26 EPS this Y64.30% Inst Trans34.47% Short Ratio2.48 Perf Half Y-4.15%
Book/sh0.47 P/B6.87 EPS next Y121.10% ROA- Target Price- Perf Year-35.01%
Cash/sh0.38 P/C8.54 EPS next 5Y- ROE- 52W Range1.52 - 6.19 Perf YTD-40.07%
Dividend- P/FCF- EPS past 5Y1.40% ROI-78.20% 52W High-47.82% Beta1.81
Dividend %- Quick Ratio1.70 Sales past 5Y- Gross Margin- 52W Low112.50% ATR0.30
Employees18 Current Ratio1.70 Sales Q/Q7.70% Oper. Margin- RSI (14)73.69 Volatility20.98% 10.76%
OptionableYes Debt/Eq0.00 EPS Q/Q-228.50% Profit Margin- Rel Volume5.21 Prev Close2.92
ShortableYes LT Debt/Eq0.00 EarningsMay 07 AMC Payout- Avg Volume206.70K Price3.23
Recom1.70 SMA2037.14% SMA5031.20% SMA200-4.28% Volume1,076,219 Change10.43%
Mar-13-20Downgrade Maxim Group Buy → Hold
Jan-10-20Initiated Oppenheimer Outperform
Apr-09-19Initiated Maxim Group Buy $10
Apr-01-19Initiated H.C. Wainwright Buy $11
Dec-20-18Initiated Ladenburg Thalmann Buy
Dec-12-16Downgrade Rodman & Renshaw Buy → Neutral $4 → $1
Apr-13-16Initiated Rodman & Renshaw Buy $15
Dec-09-15Initiated Laidlaw Buy $10
May-29-20 07:00AM  Cerecor to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire +10.43%
May-28-20 07:00AM  Cerecor Announces FDA Clearance of IND for CERC-002 in COVID-19 Induced ARDS GlobeNewswire +7.14%
May-26-20 07:00AM  Cerecor and Myriad Genetics Announce that Levels of LIGHT, a Novel Cytokine, Were Highly Correlated with Disease Severity and Mortality in COVID-19 ARDS Biomarker Study GlobeNewswire
May-13-20 06:00AM  CERC: Improved Balance Sheet to Move the Pipeline Forward Zacks Small Cap Research +6.48%
May-07-20 06:30AM  Cerecor Reports Q1 2020 Results and Update GlobeNewswire
May-04-20 09:15AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Cerecor Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Apr-24-20 01:45PM  Cerecor Announces Changes to Board of Directors GlobeNewswire
Mar-27-20 09:39PM  Big Stock Buys at Winnebago, National CineMedia -9.58%
Mar-26-20 06:30AM  Cerecor Announces Exploration of the Role of an Inflammatory Cytokine, LIGHT, in COVID-19 Patients with Acute Lung Injury Leading to Acute Respiratory Distress Syndrome GlobeNewswire
Mar-19-20 08:50AM  CERC: Data from CDG-FIRST Trial Upcoming Zacks Small Cap Research +35.64%
Mar-13-20 07:18AM  Here's Why Cerecor (NASDAQ:CERC) Must Use Its Cash Wisely Simply Wall St. +6.86%
06:59AM  Cerecor Inc. Just Released Its Yearly Earnings: Here's What Analysts Think Simply Wall St.
Mar-11-20 06:30AM  Cerecor Reports 2019 Results GlobeNewswire -12.04%
Mar-06-20 09:00AM  Cerecor Announces Appointment of H. Jeffery Wilkins MD as Chief Development Officer GlobeNewswire -6.56%
Feb-04-20 01:31PM  Done deal: Maryland biopharm firm completes acquisition of Aevi Genomic Medicine American City Business Journals
Feb-03-20 04:15PM  Cerecor and Aevi Genomic Medicine Complete Merger GlobeNewswire
Dec-23-19 10:26AM  Is Cerecor Inc. (CERC) A Good Stock To Buy? Insider Monkey +23.36%
Dec-13-19 09:50AM  CERC: Expansion in Rare and Orphan Diseases with Acquisition of Aevi Genomic Medicine Zacks Small Cap Research
Dec-10-19 03:20PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Aevi Genomic Medicine, Inc. to Independent Bank Group Inc. is Fair to Shareholders ACCESSWIRE
Dec-05-19 08:45AM  Cerecor to Acquire Aevi Genomic Medicine GlobeNewswire -8.92%
Nov-14-19 06:30AM  Cerecor Reports Third Quarter 2019 Results GlobeNewswire -9.31%
Nov-11-19 06:30AM  Cerecor Announces Clinical Updates on CERC-301 and CERC-802 GlobeNewswire
Nov-04-19 06:30AM  Cerecor Closes Deal to Sell Pediatric Portfolio GlobeNewswire
Oct-23-19 11:27AM  Cerecor (NASDAQ:CERC) Is Making Moderate Use Of Debt Simply Wall St.
Oct-14-19 06:30AM  Cerecor To Sell Pediatric Portfolio to AYTU BioScience GlobeNewswire +9.62%
Aug-21-19 07:42AM  Cerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disorder MarketWatch
06:30AM  Cerecor Receives Fast Track Designation from FDA for CERC-802 for the Treatment of Mannose-Phosphate Isomerase Deficiency GlobeNewswire
Aug-08-19 04:05PM  Cerecor Reports Second Quarter 2019 Results GlobeNewswire +20.82%
Jul-29-19 06:30AM  FDA Accepts IND Application for Cerecors Investigational Drug CERC-802 for the treatment of MPI-CDG GlobeNewswire
Jul-25-19 03:22PM  What Does Cerecor Inc.'s (NASDAQ:CERC) Balance Sheet Tell Us About It? Simply Wall St.
Jul-23-19 10:00AM  CERC: CDG FIRST Trial Underway Zacks Small Cap Research
Jul-15-19 06:30AM  Cerecor Announces First Patient Enrolled in CDG FIRST Trial GlobeNewswire
Jul-02-19 12:03PM  Drugmakers raised prices of over 40 prescription drugs Yahoo Finance Video -9.91%
Jul-01-19 06:30AM  Cerecor Announces Positive Final Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (OH) GlobeNewswire
Jun-28-19 02:19PM  18 Stocks Joining The Russell Indices Benzinga +11.48%
06:30AM  Cerecor Added to Russell 3000® Index GlobeNewswire
Jun-12-19 04:05PM  Cerecor Appoints Keith Schmidt to its Board of Directors GlobeNewswire
Jun-11-19 01:00PM  Cerecor Set to Join Russell 3000® Index GlobeNewswire +5.42%
May-13-19 02:00PM  CERC: Completion of Phase 1 Trial of CERC-801 Zacks Small Cap Research
May-09-19 04:05PM  Cerecor Reports First Quarter 2019 Results GlobeNewswire -5.86%
Apr-29-19 10:38AM  Introducing Cerecor (NASDAQ:CERC), A Stock That Climbed 42% In The Last Three Years Simply Wall St.
06:30AM  Cerecor Announces Positive Phase I Safety Data for CERC-801 in Healthy Volunteers GlobeNewswire
Apr-17-19 10:15AM  CERC: Positive Results for Phase 1 Trial of CERC-301 Zacks Small Cap Research
Apr-15-19 06:30AM  Cerecor Announces Positive Interim Results of CERC-301 in the Treatment of Neurogenic Orthostatic Hypotension (nOH) ACCESSWIRE
Apr-11-19 06:30AM  Cerecor Announces Leadership Changes ACCESSWIRE
Mar-26-19 10:30AM  CERC: Multiple Data Readouts in 2019; Commercial Unit Continues Growth Zacks Small Cap Research
Mar-18-19 04:05PM  Cerecor Reports Fourth Quarter and Full Year 2018 Results ACCESSWIRE
Mar-06-19 06:05AM  Cerecor Increases Previously Announced Bought Deal of Common Stock to $10 Million ACCESSWIRE
Mar-05-19 05:30PM  Cerecor Announces $8 Million Bought Deal Offering ACCESSWIRE -20.20%
Feb-22-19 10:11AM  Do Insiders Own Lots Of Shares In Cerecor Inc. (NASDAQ:CERC)? Simply Wall St.
Feb-19-19 08:27AM  Cerecor Receives Fast Track Designation from FDA for CERC-801 for the Treatment of PGM1 Deficiency GlobeNewswire
Feb-15-19 06:30AM  Cerecor Announces CERC-301 Granted U.S. Patent GlobeNewswire +13.00%
Jan-28-19 06:30AM  Cerecor Announces U.S. Headquarters Move Into Pharmaceutical Corridor of Rockville, Maryland GlobeNewswire
Jan-22-19 06:30AM  FDA Accepts IND Application for Cerecors Investigational Drug CERC-801 for the treatment of PGM1 Deficiency GlobeNewswire
Jan-16-19 06:30AM  FDA Grants Cerecors Three Substrate Replacement Therapies Orphan Drug Designation GlobeNewswire +15.74%
Dec-13-18 07:00AM  Antares Pharma Announces the Appointment of Peter S. Greenleaf to Companys Board of Directors GlobeNewswire
Nov-26-18 12:00PM  CERC: Unveils Rare Pediatric Disease Programs Zacks Small Cap Research
Nov-22-18 02:13PM  What Kind Of Share Price Volatility Should You Expect For Cerecor Inc (NASDAQ:CERC)? Simply Wall St.
Nov-21-18 08:55AM  Analysis: Positioning to Benefit within KemPharm, Bellerophon Therapeutics, Exela Technologies, Intec Pharma, Cerecor, and Chiasma Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-13-18 07:00AM  Cerecor Reports Third Quarter 2018 Results GlobeNewswire
Oct-31-18 04:00PM  Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation GlobeNewswire +8.47%
Oct-30-18 04:00PM  Cerecor Receives Rare Pediatric Disease Designation for CERC-801 for Patients with Inborn Error of Metabolism GlobeNewswire
Oct-02-18 09:20AM  CERC: Transformation Continues with Purchase of Ichorion Therapeutics, Inc Zacks Small Cap Research -6.22%
Sep-26-18 01:00PM  Cerecor to Participate in Upcoming Healthcare Conferences GlobeNewswire
11:29AM  Baltimore's Cerecor buys New York biotech for $26.6M in stock American City Business Journals
Sep-25-18 06:30AM  Cerecor to Acquire Ichorion Therapeutics GlobeNewswire
Aug-31-18 02:46PM  Penny Stocks to Buy Using Technical Analysis for September 2018 Investopedia
07:00AM  Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference GlobeNewswire
Aug-15-18 01:15PM  CERC: Phase 1 Trial of CERC-301 in nOH Underway Zacks Small Cap Research
Aug-09-18 06:30AM  Cerecor Reports Second Quarter 2018 Financial Results GlobeNewswire -7.63%
Aug-01-18 06:30AM  Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinsons Disease GlobeNewswire
Jul-31-18 01:37PM  Penny Stocks to Watch for August 2018 Investopedia
Jul-16-18 06:00AM  Cerecor Announces Expansion of Leadership Team GlobeNewswire
Jul-12-18 02:00AM  [$$] The drug pricing playbook: how pharma companies keep costs high Financial Times
May-22-18 08:29AM  BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board GlobeNewswire
May-19-18 10:02AM  May Top Undervalued Stock Simply Wall St.
May-17-18 09:55AM  CERC: Converting into a Fully Independent Healthcare Company Zacks Small Cap Research
08:01AM  BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business GlobeNewswire
May-11-18 08:15AM  Cerecor Reports First Quarter 2018 Financial Results GlobeNewswire -10.03%
May-10-18 07:40AM  Wired News CymaBay Therapeutics Starts Phase-2b Clinical Trials of Seladelpar for Treatment of Patients with Non-Alcoholic Steatohepatitis ACCESSWIRE
Apr-09-18 08:00AM  Cerecor Appoints Simon Pedder to its Board of Directors Marketwired -5.31%
Apr-02-18 08:00AM  Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017 Marketwired
Mar-28-18 10:02AM  Flavor Of The Month: inTEST And More Simply Wall St. -7.78%
08:00AM  Cerecor Appoints Peter Greenleaf as Chief Executive Officer Marketwired
Mar-07-18 03:15PM  Have Investors Already Priced In Cerecor Incs (NASDAQ:CERC) Growth? Simply Wall St. +9.90%
Feb-12-18 05:06PM  Cerecor Incs (NASDAQ:CERC) Insiders Recently Ramped Up Their Holdings Should You? Simply Wall St. +9.84%
09:07AM  Cerecor to Acquire Avadel Pharmaceuticals' Pediatric Assets Marketwired
Jan-10-18 07:52PM  What Does Cerecor Incs (NASDAQ:CERC) Ownership Structure Look Like? Simply Wall St. -11.46%
Dec-26-17 09:00AM  Cerecor, Inc. :CERC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube +9.57%
Dec-25-17 05:45PM  What Are The Drivers Of Cerecor Incs (NASDAQ:CERC) Risks? Simply Wall St.
Dec-18-17 09:05AM  Can Cerecor Inc (NASDAQ:CERC) Continue To Outperform Its Industry? Simply Wall St. +11.86%
Dec-08-17 10:33AM  Should You Buy Cerecor Inc (CERC) At This PE Ratio? Simply Wall St.
Nov-29-17 07:30AM  This Unknown Cannabis Stock Could Have Big Upside as Wall Street Takes Notice ACCESSWIRE +36.36%
Nov-21-17 07:40AM  Corporate News Blog - Cerecor Acquired TRx Pharmaceuticals ACCESSWIRE
Nov-20-17 12:45PM  Is It The Right Time To Buy Cerecor Inc (CERC)? Simply Wall St.
Nov-17-17 10:35AM  Baltimore pharmaceutical company acquiring North Carolina firm for at least $27 million American City Business Journals
08:30AM  Cerecor Announces Leadership Changes Marketwired
08:15AM  Cerecor Acquires TRx Pharmaceuticals Marketwired
08:02AM  Best Undervalued Stock Picks Simply Wall St.
Nov-09-17 11:45AM  CERC: With An Infusion of Non-dilutive Capital, Cerecor Ready to Move the Pipeline Forward Zacks Small Cap Research
Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Ulesfia, Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension, as well as Flexichamber a medical device. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-406 for the treatment of Parkinson's disease; CERC-425, an orally active small molecule; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and CERC-913, a protide nucleotide for the treatment of mitochondrial disorder. It also developing preclinical therapies CERC-801, CERC-802, and CERC-803 for the treatment of inherited metabolic disorders. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Rockville, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cerecor Inc.10% OwnerApr 15Sale1.5592,777144,0929,713,068Apr 27 09:30 AM
ARMISTICE CAPITAL, LLCDirectorApr 03Buy2.164,2809,245832,194Apr 07 04:59 PM
ARMISTICE CAPITAL, LLCDirectorMar 31Buy2.3326,61162,004827,914Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 30Buy2.3549,303115,862801,303Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 27Buy2.4336,00087,480752,000Mar 31 05:58 PM
ARMISTICE CAPITAL, LLCDirectorMar 23Buy2.521,3743,462716,000Mar 24 04:47 PM
ARMISTICE CAPITAL, LLCDirectorMar 20Buy2.509,62624,065714,626Mar 24 04:47 PM
ARMISTICE CAPITAL, LLCDirectorMar 19Buy2.601,5674,074705,000Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorMar 18Buy1.9128,43354,307703,433Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorMar 17Buy2.051,951,2193,999,99928,160,605Mar 19 06:39 PM
ARMISTICE CAPITAL, LLCDirectorFeb 03Buy3.98275,0001,094,500675,000Feb 05 05:43 PM
ARMISTICE CAPITAL, LLCDirectorFeb 03Buy3.98981,2823,905,50229,664,515Feb 05 05:43 PM
Calias PericlesChief Scientific OfficerDec 10Buy2.852,9138,29552,462Dec 11 04:15 PM
Miller Joseph MChief Financial OfficerDec 10Buy2.852,5987,39848,777Dec 11 04:41 PM
Harrell James Archie JrChief Commercial OfficerDec 10Buy2.853,0648,72511,618Dec 11 04:28 PM
ARMISTICE CAPITAL, LLCDirectorSep 06Buy2.951,000,0002,950,00020,683,233Sep 06 07:13 PM
ARMISTICE CAPITAL, LLCDirectorSep 04Buy3.131,200,0003,756,00019,683,233Sep 06 07:13 PM
ARMISTICE CAPITAL, LLCDirectorAug 30Buy3.2324,59179,42918,483,233Sep 03 05:50 PM
ARMISTICE CAPITAL, LLCDirectorAug 29Buy3.2117,17355,12518,458,642Sep 03 05:50 PM
Pedder SimonExecutive Chairman of the BdAug 27Buy2.986,73420,100262,734Aug 29 05:03 PM
ARMISTICE CAPITAL, LLCDirectorAug 19Buy3.602,2988,28018,441,469Aug 20 07:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 16Buy3.439,88633,90918,439,171Aug 20 07:04 PM
ARMISTICE CAPITAL, LLCDirectorAug 14Buy3.3756,842191,558400,000Aug 14 07:29 PM
ARMISTICE CAPITAL, LLCDirectorAug 13Buy3.3029,18896,320343,158Aug 14 07:29 PM
ARMISTICE CAPITAL, LLCDirectorAug 12Buy3.2013,97044,704313,970Aug 14 07:29 PM
Calias PericlesChief Scientific OfficerJun 10Buy2.854,54912,95349,549Jun 11 07:36 PM
Phillips Matthew VChief Commercial OfficerJun 10Buy2.855231,4891,020Jun 11 09:04 PM
Miller Joseph MChief Financial OfficerJun 10Buy2.851,1793,35746,179Jun 11 08:47 PM
Harrell James Archie JrExec. VP, Mktg & External CommJun 10Buy2.854,39812,5238,554Jun 11 07:51 PM
ARMISTICE CAPITAL, LLCDirectorJun 07Buy4.8810,00048,750300,000Jun 11 06:01 PM
ARMISTICE CAPITAL, LLCDirectorJun 05Buy4.975,00024,85018,429,285Jun 05 05:52 PM
ARMISTICE CAPITAL, LLCDirectorJun 03Buy4.7310,00047,30018,424,285Jun 05 05:52 PM
ARMISTICE CAPITAL, LLCDirectorMay 31Buy4.9113,80067,75818,414,285May 31 04:50 PM